J. Bartholeyns

发表

Production of human macrophages with potent antitumor properties (MAK) by culture of monocytes in the presence of GM-CSF and 1,25-dihydroxy vitamin D3.

C. Martinache, S. Canépa, M. Chokri, 1992, Anticancer research.

Analysis and Characterization of Antitumor T-cell Response After Administration of Dendritic Cells Loaded With Allogeneic Tumor Lysate to Metastatic Melanoma Patients

E. Tartour, W. Fridman, N. Bercovici, 2008, Journal of immunotherapy.

Inhibition of tumor cell proliferation by dimerized ribonuclease.

P. Baudhuin, J. Bartholeyns, 1976, Proceedings of the National Academy of Sciences of the United States of America.

Antitumoral properties and reduced toxicity of LPS targeted to macrophages via normal or mannosylated liposomes.

C. Muller, S. Dumont, F. Schuber, 1990, Anticancer research.

Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor

C. Galanos, M. Freudenberg, J. Bartholeyns, 1987, Infection and immunity.

[Immunotargeting of tumors: state of the art and prospects in 2000].

B. Robert, L. Leserman, F. Buchegger, 2000, Bulletin du cancer.

Frequency of human anti-FVIII antibodies in humanized SCID mice elicited by recombinant deleted factor VIII and by a plasma derived factor VIII.

Y. Sultan, A. Montembault, J. Bartholeyns, 1997, Journal of immunological methods.

Explanation of the observation of pancreatic ribonuclease activity at pH 4.5.

S. Moore, W. Stein, P. Blackburn, 2009, International journal of peptide and protein research.

Macrophages for Immunotherapy

J. Abastado, J. Bartholeyns, D. Loirat, 2004 .

Large scale isolation of human blood monocytes by continuous flow centrifugation leukapheresis and counterflow centrifugation elutriation for adoptive cellular immunotherapy in cancer patients.

J. Bergerat, S. Dumont, A. Bohbot, 1994, Journal of immunological methods.

Control of the antitumoral activity of human macrophages produced in large amounts in view of adoptive transfer.

P. Poindron, S. Dumont, F. Oberling, 1988, European journal of cancer & clinical oncology.

Rat interferon enhances the expression of acetycholine receptors in rat myotubes in culture

J. Warter, P. Poindron, G. Coupin, 1988, Journal of neuroscience research.

Establishment and characterization of somatic hybrids between human differentiated macrophages and mouse myeloma NS1 cells.

P. Poindron, A. Bohbot, F. Oberling, 1990, International journal of cell cloning.

Hepatic nucleases. Extrahepatic origin and association of neutral liver ribonuclease with lysosomes.

P. Baudhuin, J. Bartholeyns, C. Peeters-Joris, 1975, European journal of biochemistry.

In Vivo Tracking of Dendritic Cells in Patients With Multiple Myeloma

M. Loudovaris, L. Mileshkin, R. Hicks, 2008, Journal of immunotherapy.

Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: Toxicity and immunomodulatory effects

P. Poindron, S. Dumont, A. Bohbot, 2005, Cancer Immunology, Immunotherapy.

Characterization of Surface Markers of Continuously Growing Murine Resident Macrophages

P. Poindron, C. Muller, F. Schuber, 1988, Journal of leukocyte biology.

Inhibition of the discharge of endocytosed protein from phagosomes into lysosomes in hepatoma cells exposed to dimerized ribonuclease A.

P. Baudhuin, J. Bartholeyns, J. Quintart, 1979, The Biochemical journal.

Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats.

J. Koch-weser, J. Bartholeyns, 1981, Cancer research.

Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase.

J. Bartholeyns, M. Bouclier, 1984, Cancer research.

Subcellular distribution of ornithine decarboxylase in rat liver and accessibility of the enzyme to alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase.

J. Bartholeyns, 1983, Life sciences.

Monocytes and macrophages in cancer immunotherapy.

J. Bartholeyns, 1993, Research in immunology.

Adoptive immunotherapy with bispecific antibodies: targeting through macrophages.

M. Chokri, C. Oleron, A. Girard, 1992, Research in immunology.

Apheresis-Elutriation Program for Adoptive Immunotherapy with Autologous Activated Monocytes in Cancer Patients

J. Bergerat, P. Poindron, S. Dumont, 1991, The International journal of artificial organs.

Bispecific antibody targeting of human immunodeficiency virus type 1 (HIV-1) glycoprotein 41 to human macrophages through the Fc IgG receptor I mediates neutralizing effects in HIV-1 infection.

D. Dormont, H. Raoul, A. Mabondzo, 1992, The Journal of infectious diseases.

Induction of Lethality and Tolerance by Endotoxin Are Mediated by Macrophages through Tumor Necrosis Factor

C. Galanos, M. Freudenberg, A. Coumbos, 1988 .

Monocyte-derived dendritic cells: development of a cellular processor for clinical applications.

M. Chokri, J. Bartholeyns, J. Romet-Lemonne, 1998, Research in immunology.

Establishment and Characterization of Long‐Term Cultured Cell Lines of Murine Resident Macrophages

S. Kaufmann, R. Landmann, S. Dumont, 1988, Journal of leukocyte biology.

Enhanced urinary excretion of N1-acetylspermidine and the presence of tumors.

N. Seiler, A. Graham, J. Bartholeyns, 1981, Cancer research.

Hepatic nucleases. 1. Methods for the specific determination and characterization in rat liver.

H. Reychler, P. Baudhuin, J. Bartholeyns, 1975, European journal of biochemistry.

In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma

L. Mileshkin, H. Prince, P. Eu, 2006, Cancer Immunology, Immunotherapy.

In vitro and in vivo antitumor effect of dimerized ribonuclease A.

J. Bartholeyns, A. Zenebergh, 1979, European journal of cancer.

Pancreatic Ribonuclease: Enzymic and Physiological Properties of a Cross-Linked Dimer

S. Moore, J. Bartholeyns, 1974, Science.

Immunotherapy of murine sarcoma by adoptive transfer of resident peritoneal macrophages proliferating in culture.

P. Poindron, J. Bartholeyns, Y. Lombard, 1988, Anticancer research.

TMA-DPH A fluorescent probe of membrane dynamics in living cells

P. Poindron, G. Duportail, J. Kuhry, 1989, Cell Biophysics.

Adoptive Immunotherapy with Activated Macrophages Grown In Vitro from Blood Monocytes in Cancer Patients: A Pilot Study

A. de Gramont, I. Gorin, C. Louvet, 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

Biodistribution of indium labelled macrophages in mice bearing solid tumors

P. Poindron, M. Ebert, M. Chokri, 1990 .

Antitumoral effects of lipopolysaccharides, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution.

C. Galanos, M. Freudenberg, P. Poindron, 1989, Anticancer research.

Immunotherapy of cancer: experimental approach with activated macrophages proliferating in culture.

P. Poindron, S. Dumont, D. Hartmann, 1988, Cancer detection and prevention.

Autologous lymphocytes prevent the death of monocytes in culture and promote, as do GM-CSF, IL-3 and M-CSF, their differentiation into macrophages.

C. Martinache, S. Canépa, M. Chokri, 1993, Journal of immunological methods.

Immune control of neoplasia by adoptive transfer of macrophages: potentiality for antigen presentation and gene transfer.

J Bartholeyns, M Lopez, M. Lopez, 1994, Anticancer research.

Adoptive immunotherapy of solid tumors with activated macrophages: experimental and clinical results.

R. Andreesen, R Andreesen, J Bartholeyns, 1991, Anticancer research.

Study of the dependence of human monocytes and macrophages antitumoral properties upon TNF-alpha expression or release.

P. Poindron, S. Dumont, R. Kessler, 1990, Anticancer research.

Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate

N. Bercovici, F. Vernel-Pauillac, J. Abastado, 2006, Cancer Immunology, Immunotherapy.

Antitumor properties of (2R,5R)-6-heptyne-2,5-diamine, a new potent enzyme-activated irreversible inhibitor of ornithine decarboxylase, in rodents.

P. Mamont, P. Casara, J. Bartholeyns, 1984, Cancer research.

Role of histamine in tumor development

J. Fozard, J. Bartholeyns, 1985 .

Functional consequences of monocyte/macrophage infection by HIV1.

D. Dormont, H. Raoul, L. Ripoll, 1992, Research in immunology.

Polyamine metabolism and polyamine excretion in normal and tumor bearing rodents.

N. Seiler, J. Bartholeyns, B. Knödgen, 1985, Anticancer research.

Purification of rat liver particulate neutral ribonuclease and comparison of properties with pancreas and serum ribonucleases.

P. Baudhuin, J. Bartholeyns, 1977, Biochemical Journal.

Antibody-dependent cellular cytotoxicity and neutralization of human immunodeficiency virus type 1 by high affinity cross-linking of gp41 to human macrophage Fc IgG receptor using bispecific antibody.

D. Dormont, H. Raoul, G. Gras, 1994, The Journal of general virology.

Hepatic nuclease. 2. Association of polyadenylase, alkaline ribonuclease and deoxyribonuclease with rat-liver mitochondria.

P. Baudhuin, J. Bartholeyns, C. Peeters-Joris, 1975, European journal of biochemistry.

Treatment of metastatic lewis lung carcinoma with dl-α-difluoromethylornithine

J. Bartholeyns, 1983 .

Effect of alpha-monofluoromethyl histidine, an irreversible inhibitor of histidine decarboxylase, on gestation in mice.

J. Bartholeyns, M. Bouclier, 1982, Contraception.

Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti‐D

É. Oksenhendler, P. Bierling, A. Schaeffer, 1996, Transfusion.

Decarboxylase Enzyme-activated Irreversible Inhibitor of Histidine Antitumoral Properties of Monofluoromethylhistidine , an Involvement of Histamine in Growth of Mouse and Rat Tumors : Updated Version

J. Bartholeyns, M. Bouclier, 2006 .

In Vivo Tracking of Dendritic Cells in Patients With Multiple Myeloma

M. Loudovaris, L. Mileshkin, R. Hicks, 2008, Journal of immunotherapy.